What is Health Technology Assessment (HTA) and how does it influence reimbursement decisions?

Prepare for the Business of Healthcare and Health Policy Test. Study with multiple choice questions and explanations to ace your exam!

Multiple Choice

What is Health Technology Assessment (HTA) and how does it influence reimbursement decisions?

Health Technology Assessment looks at the value of a health technology by combining evidence on how well it works, how safe it is, and whether its benefits justify the costs. It goes beyond clinical effectiveness by weighing economic value, often using metrics like quality-adjusted life years (QALYs) to quantify benefit and incremental cost-effectiveness ratios (ICERs) to compare additional cost per extra unit of health gained. Budget impact analyses show the financial effect on a payer’s budget. This evidence is used by insurers and public payers to decide whether to reimburse the technology, at what price, and where it should sit in the formulary. For example, a new treatment might be covered at a certain price if its ICER and budget impact are favorable enough, guiding access decisions and pricing negotiations.

Health Technology Assessment looks at the value of a health technology by combining evidence on how well it works, how safe it is, and whether its benefits justify the costs. It goes beyond clinical effectiveness by weighing economic value, often using metrics like quality-adjusted life years (QALYs) to quantify benefit and incremental cost-effectiveness ratios (ICERs) to compare additional cost per extra unit of health gained. Budget impact analyses show the financial effect on a payer’s budget. This evidence is used by insurers and public payers to decide whether to reimburse the technology, at what price, and where it should sit in the formulary. For example, a new treatment might be covered at a certain price if its ICER and budget impact are favorable enough, guiding access decisions and pricing negotiations.

More practice questions